Concepedia

Prevention of in vitro hepatic stellate cells activation by the adenosine derivative compound IFC305

Gabriela Velasco-Loyden, Julio Isael Pérez‐Carreón, José Agüero, Pilar Cabrales Romero, Susana Vidrio-Gómez, Lidia Martínez-Pérez, Lucía Yañez-Maldonado, Rolando Hernández‐Muñoz, Marina Macı́as-Silva, Victoria Chagoya de Sánchez

Biochemical Pharmacology · 2010 · 23 citations · 41 references

DOI

Concepts

References

41

A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

Renata Belfort, Stephen A. Harrison, Kenneth Brown et al. · New England Journal of Medicine · 2006 · 1.8K citations · Full text

, , +13

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

Brent A. Neuschwander‐Tetri · Hepatology · 2003 · 700 citations · Full text

, , +16

Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells.

Massimo Pinzani, Loreto Gesualdo, Ghada Mohamed Sabbah et al. · Journal of Clinical Investigation · 1989 · 481 citations · Full text

, , +13

Peroxisome Proliferator-activated Receptors and Hepatic Stellate Cell Activation

Takeo Miyahara, Laura W. Schrum, Richard A. Rippe et al. · Journal of Biological Chemistry · 2000 · 472 citations · Full text

, , +13

Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase

Jason D. Weber, Daniel M. Raben, Polly J. Phillips et al. · Biochemical Journal · 1997 · 408 citations · Full text

, , +15